Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
5.72
-0.20 (-3.38%)
Jan 28, 2026, 4:00 PM EST - Market closed

Myriad Genetics Revenue

Myriad Genetics had revenue of $205.70M in the quarter ending September 30, 2025, a decrease of -3.56%. This brings the company's revenue in the last twelve months to $825.30M, up 0.21% year-over-year. In the year 2024, Myriad Genetics had annual revenue of $837.60M with 11.21% growth.

Revenue (ttm)
$825.30M
Revenue Growth
+0.21%
P/S Ratio
0.64
Revenue / Employee
$305,667
Employees
2,700
Market Cap
533.18M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024837.60M84.40M11.21%
Dec 31, 2023753.20M74.80M11.03%
Dec 31, 2022678.40M-12.20M-1.77%
Dec 31, 2021690.60M133.50M23.96%
Dec 31, 2020557.10M-81.50M-12.76%
Sep 30, 2020638.60M--
Jun 30, 2020638.60M--
Dec 31, 2019638.60M-212.50M-24.97%
Jun 30, 2019851.10M--
Dec 31, 2018851.10M107.40M14.44%
Jun 30, 2018743.70M--
Dec 31, 2017743.70M15.00M2.06%
Jun 30, 2017728.70M-42.70M-5.54%
Dec 31, 2016771.40M30.90M4.17%
Jun 30, 2016740.50M-13.30M-1.76%
Dec 31, 2015753.80M30.70M4.25%
Jun 30, 2015723.10M-55.10M-7.08%
Jun 30, 2014778.20M165.00M26.91%
Jun 30, 2013613.20M117.20M23.63%
Jun 30, 2012496.01M93.92M23.36%
Jun 30, 2011402.08M39.44M10.87%
Jun 30, 2010362.65M36.12M11.06%
Jun 30, 2009326.53M103.67M46.52%
Jun 30, 2008222.86M77.57M53.39%
Jun 30, 2007145.29M31.01M27.13%
Jun 30, 2006114.28M31.87M38.68%
Jun 30, 200582.41M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Neogen880.32M
NeoGenomics709.16M
OPKO Health642.07M
CareDx358.00M
Castle Biosciences343.53M
Fulgent Genetics315.55M
MDxHealth103.07M
Prenetics Global77.08M
Revenue Rankings